Thats why VVUS and OREX are on their Balls
ARNA is the only one with real science and a business model based on 19 years of experience and the best receptor technology in biotech
Once the Valeant matter is settled biotech stocks and going to unwind like we never seen before. IMO ARNA is going to do incredible
And Sean may want to take a look at the Phase I data for 334 that delivered never before seen numbers in response
Harry stated Eisai was going to take it easier on marketing until CVOT. Our sources in NJ HQ told us in Sept they where going to spend big when Belviq XR gets the FDA nod. According to reps in the field Belviq's twice a day dose was the number one reason Belviq was not achieving superstar status, Users love it but most users wont go two doses and that is the only reason Contrave had any lead.
I see no selling going on,.... Bounce trades HFT to HFT and nobody else want to play due to tightly held positions